[ad_1] Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) current P / S is a bit impressive 289.43. The entire Biotechnology group has an average P / S ratio of 256.17, which is significantly worse …
Read More »Galmed Pharmaceuticals Ltd. (GLMD) and Amicus Therapeutics, Inc. (FOLD)
